Table 2.

Oberved and relative 5-year survival of ophthalmic, other extranodal and nodal non-Hodgkin’s lymphoma for all races, 1999–2006^†, Surveillance, Epidemiology, and End Results 13.

Type of NHL	Male and female				Male				Female
	Observed survival (%)	SE (%)	95% LCI (%)	95% UCI (%)	Observed survival (%)	SE (%)	95% LCI (%)	95% UCI (%)	Observed survival (%)	SE (%)	95% LCI (%)	95% UCI (%)
NHL	58.4	0.2	57.9	58.9	56.7	0.3	56.0	57.4	60.4	0.4	59.7	61.1
Nodal NHL	56.1	0.3	55.5	56.7	54.9	0.4	54.0	55.7	57.6	0.5	56.7	58.5
Extranodal NHL	63.0	0.4	62.1	63.8	60.4	0.6	59.3	61.6	65.8	0.6	64.6	67.0
Ophthalmic NHL	75.5	1.9	71.6	78.9	75.2	2.9	68.9	80.3	75.7	2.4	70.6	80.1
Ocular adnexal NHL	76.6	1.9	72.7	80.0	75.6	2.9	69.3	80.8	77.3	2.4	72.2	81.6
Non-ophthalmic extranodal NHL	62.4	0.4	61.5	63.2	59.9	0.6	58.7	61.0	65.2	0.6	64.0	66.4
	Relative survival (%)	SE (%)	95% LCI (%)	95% UCI (%)	Relative survival (%)	SE (%)	95% LCI (%)	95% UCI (%)	Relative survival (%)	SE (%)	95% LCI (%)	95% UCI (%)
NHL	68.3	0.3	67.7	68.8	66.1	0.4	65.3	66.9	70.8	0.4	70.0	71.6
Nodal NHL	65.6	0.4	64.9	66.3	63.9	0.5	63.0	64.9	67.7	0.5	66.6	68.7
Extranodal NHL	73.4	0.5	72.5	74.4	70.4	0.7	69.1	71.7	76.8	0.7	75.4	78.2
Ophthalmic NHL	88.4	2.2	83.3	92.0	88.0	3.4	79.4	93.1	88.6	2.8	81.6	93.1
Ocular adnexal NHL	89.7	2.2	84.5	93.2	88.6	3.4	79.7	93.7	90.4	2.8	83.2	94.7
Non-ophthalmic extranodal NHL	72.7	0.5	71.7	73.7	69.7	0.7	68.3	71.0	76.1	0.7	74.7	77.5

^†Incidence 1999–2006, follow-up through 2007.

LCI: Lower confidence interval; NHL: Non-Hodgkin’s lymphoma; SE: Standard error; UCI: Upper confidence interval.